Hybrigenics S.A. | Mutual Funds

Mutual Funds that own Hybrigenics S.A.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Arcalis
2,067
0%
0
0%
12/31/2015

About Hybrigenics

View Profile
Address
3-5, impasse Reille
Paris Ile-de-France 75014
France
Employees -
Website http://www.hybrigenics.com
Updated 07/08/2019
Hybrigenics SA operates as a biopharmaceutical company, which engages in the research and development of targets and therapies against proliferative diseases. It develops inecalcitol for the treatment of prostate cancer, chronic lymphocytic leukemia, and chronic myeloid leukemia. The company was founded on December 29, 1997 and is headquartered in Paris, France.